Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 19, 2019 - Issue 3
Submit an article Journal homepage
417
Views
9
CrossRef citations to date
0
Altmetric
Review

ALK testing methods: is there a winner or loser?

Yuka KozumaDepartment of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan;Department of Surgery and Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanView further author information
,
Gouji ToyokawaDepartment of Surgery and Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanView further author information
&
Takashi SetoDepartment of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, JapanCorrespondence[email protected]
View further author information
Pages 237-244 | Received 18 Jul 2018, Accepted 19 Dec 2018, Published online: 28 Dec 2018

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mau Ern Poh, Soon Hin How, Gwo Fuang Ho, Yong Kek Pang, Harissa H Hasbullah, Lye Mun Tho, Ibtisam Muhamad Nor, Bee Chiu Lim, Kean Fatt Ho, Muthukkumaran Thiagarajan, Azlina Samsudin, Azza Omar, Choo Khoon Ong, Sing Yang Soon, Justin Yu Kuan Tan & Muhammad Adil Zainal Abidin. (2023) Real-World Treatment and Outcomes of ALK-Positive Metastatic Non–Small Cell Lung Cancer in a Southeast Asian Country. Cancer Management and Research 15, pages 31-41.
Read now

Articles from other publishers (8)

Iolanda Capone, Fabio Bozzi, Gian Paolo Dagrada, Paolo Verderio, Elena Conca, Adele Busico, Maria Adele Testi, Valentina Monti, Matteo Duca, Claudia Proto, Silvia Damian, Alberta Piccolo, Federica Perrone, Elena Tamborini, Andrea Devecchi, Paola Collini, Daniele Lorenzini, Andrea Vingiani, Luca Agnelli & Giancarlo Pruneri. (2022) Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples. Exploration of Targeted Anti-tumor Therapy, pages 582-597.
Crossref
Nina Pujol, Simon Heeke, Christophe Bontoux, Jacques Boutros, Marius Ilié, Véronique Hofman, Charles-Hugo Marquette, Paul Hofman & Jonathan Benzaquen. (2022) Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing. Journal of Personalized Medicine 12:10, pages 1684.
Crossref
Zaixiang Fu, Ganggui Zhu, Liquan Wang, Shen Hu, Lu Cheng & Fuyi Liu. (2022) Case Report: A Pregnant Woman Diagnosed as ALK-Rearrangement Lung Large Cell Neuroendocrine Cancer With Brain Metastasis. Frontiers in Oncology 12.
Crossref
Fernando Schmitt, Alessia Di Lorito & Philippe Vielh. (2021) Molecular Testing on Cytology for Gene Fusion Detection. Frontiers in Medicine 8.
Crossref
Jose Luis Leal, Geoffrey Peters, Marcin Szaumkessel, Trishe Leong, Khashayar Asadi, Gareth Rivalland, Hongdo Do, Clare Senko, Paul L. Mitchell, Chai Zi Quing, Alexander Dobrovic, Bibhusal Thapa & Thomas John. (2020) NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer. Lung Cancer 146, pages 154-159.
Crossref
Rossella Bruno & Gabriella Fontanini. (2020) Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review. Diagnostics 10:8, pages 521.
Crossref
Gokce A. Toruner, Zhenya Tang, Guilin Tang, L. Jeffrey Medeiros & Shimin Hu. (2020) Low ALK FISH positive metastatic non-small cell lung cancer (NSCLC) patients have shorter progression-free survival after treatment with ALK inhibitors. Cancer Genetics 241, pages 57-60.
Crossref
Julian Pinsolle, Anne McLeer-Florin, Matteo Giaj Levra, Florence de Fraipont, Camille Emprou, Elisa Gobbini & Anne-Claire Toffart. (2019) Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and Personalized Medicine. Frontiers in Medicine 6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.